Invesco’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25M | Buy |
78,140
+8,181
| +12% | +$235K | ﹤0.01% | 2530 |
|
|
2025
Q1 | $2.35M | Sell |
69,959
-228,295
| -77% | -$7.66M | ﹤0.01% | 2474 |
|
|
2024
Q4 | $15.2M | Buy |
298,254
+42,954
| +17% | +$2.2M | ﹤0.01% | 1620 |
|
|
2024
Q3 | $13M | Buy |
255,300
+73,701
| +41% | +$3.77M | ﹤0.01% | 1701 |
|
|
2024
Q2 | $8.13M | Buy |
181,599
+4,656
| +3% | +$209K | ﹤0.01% | 1918 |
|
|
2024
Q1 | $8.28M | Buy |
176,943
+5,106
| +3% | +$239K | ﹤0.01% | 1922 |
|
|
2023
Q4 | $6.11M | Sell |
171,837
-5,536
| -3% | -$197K | ﹤0.01% | 2131 |
|
|
2023
Q3 | $5.28M | Buy |
177,373
+139,796
| +372% | +$4.16M | ﹤0.01% | 2175 |
|
|
2023
Q2 | $677K | Sell |
37,577
-833
| -2% | -$15K | ﹤0.01% | 3080 |
|
|
2023
Q1 | $617K | Buy |
38,410
+20,129
| +110% | +$323K | ﹤0.01% | 3134 |
|
|
2022
Q4 | $335K | Sell |
18,281
-366
| -2% | -$6.7K | ﹤0.01% | 3442 |
|
|
2022
Q3 | $366K | Sell |
18,647
-2,272
| -11% | -$44.6K | ﹤0.01% | 3395 |
|
|
2022
Q2 | $390K | Buy |
20,919
+1,576
| +8% | +$29.4K | ﹤0.01% | 3432 |
|
|
2022
Q1 | $425K | Sell |
19,343
-170,892
| -90% | -$3.75M | ﹤0.01% | 3442 |
|
|
2021
Q4 | $5.4M | Buy |
190,235
+173,734
| +1,053% | +$4.94M | ﹤0.01% | 2354 |
|
|
2021
Q3 | $347K | Buy |
16,501
+2,799
| +20% | +$58.9K | ﹤0.01% | 3560 |
|
|
2021
Q2 | $258K | Buy |
+13,702
| New | +$258K | ﹤0.01% | 3662 |
|